AI Article Synopsis

  • In Parkinson's disease, axons of dopaminergic neurons deteriorate before their cell bodies, and calcium influx may play a role in this neuronal loss.
  • In a study using two mouse models of Parkinson's, differing impacts on voltage-gated calcium channels (VGCCs) were observed: L-type VGCCs were linked to pacemaker firing in G2019S mice, while T-type VGCCs showed decreased contribution in cNurr1 mice.
  • The research highlights how oxidative stress influences the function of these VGCCs in the somatic region of dopaminergic neurons, but not at the axon terminals.

Article Abstract

In Parkinson's disease (PD), axons of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) degenerate before their cell bodies. Calcium influx during pacemaker firing might contribute to neuronal loss, but it is not known if dysfunctions of voltage-gated calcium channels (VGCCs) occur in DA neurons somata and axon terminals. We investigated T-type and L-type VGCCs in SNc-DA neurons of two mouse models of PD: mice with a deletion of the Nurr1 gene in DA neurons from an adult age (cNurr1 mice), and mice bearing the G2019S mutation in the gene coding for LRRK2 (G2019S mice). Adult cNurr1 mice displayed motor and DA deficits, while middle-aged G2019S mice did not. The number and morphology of SNc-DA neurons, most of their intrinsic membrane properties and pacemaker firing were unaltered in cNurr1 and G2019S mice compared to their control and wild-type littermates. L-type VGCCs contributed to the pacemaker firing of SNc-DA neurons in G2019S mice, but not in control, wild-type, and cNurr1 mice. In cNurr1 mice, but not G2019S mice, the contribution of T-type VGCCs to the pacemaker firing of SNc-DA neurons was reduced, and somatic dopamine-D2 autoreceptors desensitized more. Altered contribution of L-type and T-type VGCCs to the pacemaker firing was not observed in the presence of a LRRK2 kinase inhibitor in G2019S mice, and in the presence of a flavonoid with antioxidant activity in G2019S and cNurr1 mice. The role of L-type and T-type VGCCs in controlling dopamine release from axon terminals in the striatum was unaltered in cNurr1 and G2019S mice. Our findings uncover opposite changes, linked to oxidative stress, in the function of two VGCCs in DA neurons somata, but not axon terminals, in two different experimental PD models.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082048PMC
http://dx.doi.org/10.1038/s41531-023-00500-5DOI Listing

Publication Analysis

Top Keywords

g2019s mice
28
pacemaker firing
20
cnurr1 mice
20
snc-da neurons
16
mice
15
axon terminals
12
t-type vgccs
12
g2019s
9
cnurr1
8
neurons
8

Similar Publications

Article Synopsis
  • Research indicates that SARS-CoV-2 infection can increase the risk of developing parkinsonian symptoms when combined with the mitochondrial toxin MPTP, particularly in genetically modified mice expressing human ACE2 receptors.
  • The study found that while both mRNA and protein-based vaccines can mitigate neurodegeneration in wild-type (WT) mice, only the protein-based vaccine was effective in protecting G2019S LRRK2 mutant mice from SARS-CoV-2 related neurological damage.
  • Overall, the findings emphasize how environmental toxins and genetic predisposition contribute to the development of neurological diseases after viral infections, as well as the potential protective effects of vaccines.
View Article and Find Full Text PDF

Autophagic dysfunction is a hallmark of neurodegenerative disease, leaving neurons vulnerable to the accumulation of damaged organelles and proteins. However, the late onset of diseases suggests that compensatory quality control mechanisms may be engaged to delay the deleterious effects induced by compromised autophagy. Neurons expressing common familial Parkinson's disease (PD)-associated mutations in LRRK2 kinase exhibit defective autophagy.

View Article and Find Full Text PDF

polymorphisms (G2019S/N2081D) that increase susceptibility to Parkinson's disease and Crohn's disease (CD) lead to LRRK2 kinase hyperactivity and suppress autophagy. This connection suggests that LRRK2 kinase inhibition, a therapeutic strategy being explored for Parkinson's disease, may also benefit patients with CD. Paneth cell homeostasis is tightly regulated by autophagy, and their dysfunction is a precursor to gut inflammation in CD.

View Article and Find Full Text PDF

P21 activated kinase 6 (PAK6) is a serine-threonine kinase with physiological expression enriched in the brain and overexpressed in a number of human tumors. While the role of PAK6 in cancer cells has been extensively investigated, the physiological function of the kinase in the context of brain cells is poorly understood. Our previous work uncovered a link between PAK6 and the Parkinson's disease (PD)-associated kinase LRRK2, with PAK6 controlling LRRK2 activity and subcellular localization via phosphorylation of 14-3-3 proteins.

View Article and Find Full Text PDF

The leucine-rich repeat kinase 2 (LRRK2) phosphorylates a subset of RAB GTPases, and their phosphorylation levels are elevated by Parkinson's disease (PD)-linked mutations of LRRK2. However, the precise function of the LRRK2-regulated RAB GTPase in the brain remains to be elucidated. Here, we identify RAB12 as a robust LRRK2 substrate in the mouse brain through phosphoproteomics profiling and solve the structure of RAB12-LRRK2 protein complex through Cryo-EM analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!